Author: Wu, Yuhan; Peng, Zhuobing; Yan, Yongxue; Hu, Jintao; Wang, Yalong; Wang, Xiaoyu; Peng, Ruchao; Watterson, Daniel; Shi, Yi
Title: Current knowledge of COVID-19: advances, challenges and future perspectives Cord-id: 4ihrry3e Document date: 2021_6_4
ID: 4ihrry3e
Snippet: The pandemic Coronavirus Disease 2019 (COVID-19) has already evoked massive influence. The global pandemic has been ravaging the whole world for a year, with the number of confirmed human infection cases over 150 million and a death toll exceeding 3 million. Although the genomic sequence of the cognate pathogen SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) has been quickly determined, there are still many unknown aspects, including the virus origin and evolution trend, and also th
Document: The pandemic Coronavirus Disease 2019 (COVID-19) has already evoked massive influence. The global pandemic has been ravaging the whole world for a year, with the number of confirmed human infection cases over 150 million and a death toll exceeding 3 million. Although the genomic sequence of the cognate pathogen SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) has been quickly determined, there are still many unknown aspects, including the virus origin and evolution trend, and also the effectiveness of current vaccines and drugs against the mutating virus. This review summarizes current knowledge and advances about COVID-19, including virus origin, transmission and infection, with the aim to improve understanding of COVID-19 and provide a new perspective for future studies.
Search related documents:
Co phrase search for related documents- abnormal hepatic and acute respiratory distress syndrome: 1, 2
- abnormal hepatic and acute respiratory distress syndrome ards: 1, 2
- accelerate deterioration and acute respiratory: 1
- accumulate data and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- accumulate data and acute respiratory distress syndrome: 1
- accumulate data and acute respiratory distress syndrome ards: 1
- acquire high risk and acute respiratory: 1
- action study and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- action study and acute respiratory distress syndrome: 1
- action study and acute respiratory distress syndrome ards: 1
- action study and long term exposure: 1
- acute respiratory and adenovirus vector: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- acute respiratory and live virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory and long term exposure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute respiratory and long term protection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- acute respiratory and long virus survive: 1
- acute respiratory and low moisture: 1
- acute respiratory and low temperature: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- acute respiratory and lung attack: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date